High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity.
OBJECTIVE
The observed relaxivity of gadolinium-based contrast agents has contributions from the water molecule(s) that bind directly to the gadolinium ion (inner-sphere water), long-lived water molecules and exchangeable protons that make up the second-sphere of coordination, and water molecules that diffuse near the contrast agent (outer-sphere). Inner- and second-sphere relaxivity can both be increased by optimization of the lifetimes of the water molecules and protons in these coordination spheres, the rotational motion of the complex, and the electronic relaxation of the gadolinium ion. We sought to identify new high-relaxivity contrast agents by systematically varying the donor atoms that bind directly to gadolinium to increase inner-sphere relaxivity and concurrently including substituents that influence the second-sphere relaxivity.


METHODS
Twenty gadolinium-1,4,7,10-tetraazacyclo-dodecane-N,N',N″,N'″-tetraacetato derivatives were prepared and their relaxivity determined in presence and absence of human serum albumin as a function of temperature and magnetic field. Data was analyzed to extract the underlying molecular parameters influencing relaxivity. Each compound had a common albumin-binding group and an inner-sphere donor set comprising the 4 tertiary amine N atoms from cyclen, an α-substituted acetate oxygen atom, 2 amide oxygen atoms, an inner-sphere water oxygen atom, and a variable donor group. Each amide nitrogen was substituted with different groups to promote hydrogen bonding with second-sphere water molecules.


RESULTS
Relativities at 0.47 and 1.4 T, 37°C, in serum albumin ranged from 16.0 to 58.1 mM(-1)s(-1) and from 12.3 to 34.8 mM(-1)s(-1), respectively. The reduction of inner-sphere water exchange typical of amide donor groups could be offset by incorporating a phosphonate or phenolate oxygen atom donor in the first coordination sphere, resulting in higher relaxivity. Amide nitrogen substitution with pendant phosphonate or carboxylate groups increased relaxivity by as much as 88% compared with the N-methyl amide analog. Second-sphere relaxivity contributed as much as 24 and 14 mM(-1)s(-1) at 0.47 and 1.4 T, respectively.


CONCLUSIONS
Water/proton exchange dynamics in the inner- and second-coordination sphere can be predictably tuned by choice of donor atoms and second-sphere substituents, resulting in high-relaxivity agents.
Jacques
Vincent
V
Epix Pharmaceuticals, Cambridge, MA, USA.
Dumas
Stéphane
S
Sun
Wei-Chuan
WC
Troughton
Jeffrey S
JS
Greenfield
Matthew T
MT
Caravan
Peter
P
D000418:Albumins / Q000737:chemistry* / Q000378:metabolism; D055598:Chemical Phenomena; D003287:Contrast Media / Q000737:chemistry* / Q000378:metabolism; D005682:Gadolinium / Q000097:blood / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009682:Magnetic Resonance Spectroscopy; D011485:Protein Binding; D011522:Protons; D014867:Water / Q000737:chemistry
D000418:Albumins; D003287:Contrast Media; D011522:Protons; D014867:Water; D005682:Gadolinium
Inorg Chem. 2007 Jun 25;46(13):5260-70
17539632
Inorg Chem. 2007 Apr 30;46(9):3576-84
17425306
Invest Radiol. 2009 Nov;44(11):697-704
19809344
Inorg Chem. 2007 Aug 6;46(16):6632-9
17625839
Radiology. 1993 Jun;187(3):701-6
8497616
Chemphyschem. 2005 Dec 9;6(12):2570-7
16294353
J Am Chem Soc. 2008 May 7;130(18):6025-39
18393503
Invest Radiol. 1987 Aug;22(8):665-71
3667174
J Am Chem Soc. 2002 Mar 27;124(12):3152-62
11902904
Chem Soc Rev. 2006 Jun;35(6):512-23
16729145
J Magn Reson. 2003 Jun;162(2):229-40
12810007
Invest Radiol. 2009 Mar;44(3):146-50
19151606
Magn Reson Med. 1991 Dec;22(2):339-42; discussion 343-6
1812368
Invest Radiol. 2007 Aug;42(8):586-95
17620942
Chemistry. 2001 Feb 2;7(3):600-10
11261657
Inorg Chem. 2004 Oct 4;43(20):6313-23
15446878
Invest Radiol. 1991 Nov;26(11):969-74
1743920
Eur J Biochem. 1971 Jul 29;21(2):204-9
4327451
Invest Radiol. 2010 Sep;45(9):554-8
20697225
Chemistry. 2001 Jan 5;7(1):288-96
11205022
Magn Reson Imaging. 1985;3(1):11-6
3923289
Invest Radiol. 2008 Feb;43(2):141-4
18197066
Contrast Media Mol Imaging. 2006 Jan-Feb;1(1):30-9
17193598
Magn Reson Med. 1994 Jan;31(1):1-8
8121264
Chem Rev. 1999 Sep 8;99(9):2293-352
11749483
Angew Chem Int Ed Engl. 2005 Feb 25;44(10):1480-4
15580594
J Am Chem Soc. 2006 Jun 21;128(24):7807-16
16771494
Chemphyschem. 2006 Jul 17;7(7):1590-7
16810729
J Am Chem Soc. 2001 Aug 8;123(31):7601-9
11480981
Dalton Trans. 2007 Jan 28;(4):493-501
17213936
Acc Chem Res. 2003 Oct;36(10):783-90
14567712
Angew Chem Int Ed Engl. 2007;46(43):8171-3
17893943
Invest Radiol. 2010 Sep;45(9):507-12
20697223
Invest Radiol. 2010 Oct;45(10):600-12
20808235
Inorg Chem. 2001 Dec 17;40(26):6580-7
11735466
Chemistry. 2008;14(24):7250-8
18601236
Angew Chem Int Ed Engl. 1999 Nov 2;38(21):3192-3194
10556899
Acc Chem Res. 2009 Jul 21;42(7):893-903
19537782
Chemistry. 2005 Apr 8;11(8):2373-84
15685711
Magn Reson Med. 1991 Jan;17(1):164-78
1648652
Chem Rev. 2005 Jun;105(6):1923-59
15941206
Contrast Media Mol Imaging. 2009 Mar-Apr;4(2):89-100
19177472
Magn Reson Med. 1984 Dec;1(4):478-95
6571571
Biochim Biophys Acta. 1986 Oct 1;883(3):460-7
3756213
Invest Radiol. 2001 Feb;36(2):82-6
11224755
Magn Reson Med. 1993 Nov;30(5):583-91
8259058
Acc Chem Res. 2009 Jul 21;42(7):822-31
19534516
Invest Radiol. 2010 Oct;45(10):662-8
20733508
Circulation. 2009 Apr 7;119(13):1768-75
19307474
Kidney Int. 2007 Aug;72(3):260-4
17507905
Acc Chem Res. 2009 Jul 21;42(7):938-47
19505089